HG-87 COMBINED APPLICATION OF TEMOZOLOMIDE AND THE ONCOLYTIC PARVOVIRUS H-1 INCREASES CYTOTOXIC EFFECTS IN CELL CULTURE AND ANIMAL MODELS OF PEDIATRIC GLIOBLASTOMA

Podobne knjige/članki

• Preclinical Testing of an Oncolytic Parvovirus: Standard Protoparvovirus H-1PV Efficiently Induces Osteosarcoma Cell Lysis In Vitro
  od: Geiss, Carsten, et al.
  Izdano: (2017)
• Preclinical Testing of an Oncolytic Parvovirus in Ewing Sarcoma: Protoparvovirus H-1 Induces Apoptosis and Lytic Infection In Vitro but Fails to Improve Survival In Vivo
  od: Lacroix, Jeannine, et al.
  Izdano: (2018)
• Pediatric and Adult High-Grade Glioma Stem Cell Culture Models Are Permissive to Lytic Infection with Parvovirus H-1
  od: Josupeit, Rafael, et al.
  Izdano: (2016)
• Oncolytic effects of parvovirus H-1 in medulloblastoma are associated with repression of master regulators of early neurogenesis
  od: Lacroix, Jeannine, et al.
  Izdano: (2014)
• Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1
  od: Moehler, Markus, et al.
  Izdano: (2011)